Orbis Medicines raised EUR 90 million in a Series A funding round led by NEA to develop their pipeline of next-generation oral macrocycle drugs.
Amount Raised
€90 Million
Round Type
Series A
CopenhagenBiotechnologyInvestors
Description
Orbis Medicines announced the close of a EUR 90 million Series A funding round, bringing their total raised to EUR 116 million. The funds will support the development of their oral macrocycle drugs, called ‘nCycles’, which aim to provide high-value alternatives to traditional biologic drugs.
Quick answer
Orbis Medicines raised €90 Million in a Series A round, dated January 6, 2025. Investors: New Enterprise Associates, Eli Lilly And Company, Cormorant, Export And Investment Fund Of Denmark, Novo Holdings and Forbion. Orbis Medicines is based in Copenhagen, Capital Region Of Denmark, Denmark.
- How much did Orbis Medicines raise?
- Orbis Medicines raised €90 Million in a Series A round on January 6, 2025.
- Who invested in Orbis Medicines?
- New Enterprise Associates, Eli Lilly And Company, Cormorant, Export And Investment Fund Of Denmark, Novo Holdings and Forbion are named as investors in this round.
- What does Orbis Medicines do?
- Orbis Medicines is a biotechnology company focused on pioneering a new era for oral macrocycle drug discovery.
- Where is Orbis Medicines based and how big is it?
- Orbis Medicines is based in Copenhagen, Capital Region Of Denmark, Denmark. Fundz records about 45 employees.
- Who are the decision-makers at Orbis Medicines?
- Fundz holds 5 contacts at Orbis Medicines, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Orbis Medicines that raised within 45 days of this round, from Fundz verified event records.
- Variational AI raised $5.5M (Seed) on February 20, 2025.
- Resynergi raised $18M (Series B) on February 20, 2025.
- ABIONYX Pharma raised $9.1M (Grant) on February 20, 2025.
- EG 427 raised $28M (Series B) on February 20, 2025.
- Atrandi Biosciences raised $25M (Series A) on February 20, 2025.
- Noah Labs raised $3.1M (Seed) on February 20, 2025.
Who to call at Orbis Medicines, and when
A new round usually means Orbis Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orbis Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orbis Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orbis Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orbis Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOrbis Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.